Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kellogg Capital Group was a prominent financial services firm and market maker primarily known for its role as a specialist on the New York Stock Exchange (NYSE). While the firm operated across various asset classes, it was not a life sciences or biotechnology company, though it frequently acted as a market maker for publicly traded healthcare and biotech stocks. The company's operations were centered on providing liquidity and execution services to institutional clients and managing specialist books for listed companies. In 2012, the firm's specialist business was acquired by Knight Capital Group, which subsequently merged to form KCG Holdings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kellogg Capital Group.